透過您的圖書館登入
IP:3.143.23.176
  • 期刊

肝癌患者行切肝合併膽囊切除手術後腹瀉之危險因子探討

Risk Factors of Diarrhea after Cholecystectomy and Hepatectomy in Patients with Hepatocellular Carcinoma

摘要


患者在接受膽囊切除手術後腹瀉的發生率甚高,並影響患者術後的生活品質,本研究在探討肝細胞癌行肝葉併膽囊切除術後發生腹瀉盛行率之危險因子探討。研究採回溯性設計,單一醫學中心,從2005年01月至2015年08月共有209位符合納入。腹瀉診斷為每天解大於等於三次水便,一週發生三次以上。分為腹瀉及無腹瀉兩組並追蹤至術後三個月,分析術後腹瀉之重要危險因子。多變量邏輯迴歸分析術後 三個月腹瀉的重要危險因子亦為糖尿病(OR=19.355,95%信賴區問=2.992-125.203,p=0.002)。接受切肝合併膽囊切除手術後有糖尿病病史出現腹瀉情形應更須注意其生活品質。

關鍵字

肝細胞癌 膽囊切除 腹瀉 糖尿病

並列摘要


High frequency of diarrhea has been found in patients with cholecystectomy. Diarrhea has a significant impact on quality of life among patients who have undergone cholecystectomy. Herein, we aim to investigate prevalence and risk factors of diarrhea after incidental cholecystectomy during hepatectomy in patients with hepatocellular carcinoma (HCC). This is a retrospective study and patients who underwent incidental cholecystectomy after hepatectomy between January 2005 and August 2015 at a single medical center were enrolled. A total of 209 cases were included in the study. Diarrhea was defined as the passing of three or more liquid stools per day. All patients were divided into two groups, patients with and without diarrhea at the time point of three months after incidental cholecystectomy during hepatectomy. Multiple logistic analysis revealed that history of diabetes (OR = 19.335, 95% CI: 2.992–125.203, p=0.002) at three months is risk factor associated with diarrhea after incidental cholecystectomy during hepatectomy. In order to reduce the risk of postoperative diarrhea and to enhance the quality of life in HCC patient with diabetes, long term follow up of nutritional status and liver function is also suggested.

參考文獻


Yueh TP, Chuang MT, Chen FY: The associated factors of diarrhea in post laparoscopic cholecystectomy patients. Hungkuang Acdemic Review 2011;64:47-56. doi: 10.6615/HAR.201109.64.05"
Lai YC, Chuang LM: Gastrointestinal complications of diabetes. Taiwan Society of Internal Medicine 2009;20:409-16. doi: 10.6314/JIMT.2009.20(5).04"
PonS F, Varela M, Llovet JM: Staging systems in hepatocellular carcinoma. HPB 2005;7:35-41. doi: 10.1080/13651820410024058"
Ryder S D: Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52(Suppl III):iii1–iii8. doi: 10.1136/gut.52.suppl_3.iii1"
Shi M, Guo RP, Lin XJ, et al: Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007;245:36-43. doi: 10.1097/01.sla.0000231758.07868.71"

被引用紀錄


劉筱涵、阮薰慧(2020)。照護一位大腸癌術後吻合處滲漏病人之護理經驗榮總護理37(3),313-319。https://doi.org/10.6142/VGHN.202009_37(3).0011

延伸閱讀